Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. LFWD
stocks logo

LFWD

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
8.01M
+6.19%
-0.087
-94.99%
7.70M
+52.96%
-0.090
-80.43%
9.10M
+58.98%
-0.080
-86.21%
Estimates Revision
The market is revising Upward the revenue expectations for Lifeward Ltd. (LFWD) for FY2025, with the revenue forecasts being adjusted by 0.64% over the past three months. During the same period, the stock price has changed by 32.08%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.64%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+2.29%
In Past 3 Month
Stock Price
Go Up
up Image
+32.08%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Lifeward Ltd (LFWD.O) is -2.21, compared to its 5-year average forward P/E of -3.88. For a more detailed relative valuation and DCF analysis to assess Lifeward Ltd 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-3.88
Current PE
-2.21
Overvalued PE
-1.16
Undervalued PE
-6.60

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.54
Undervalued EV/EBITDA
-0.55

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
4.55
Current PS
0.00
Overvalued PS
9.33
Undervalued PS
-0.23
Intellectia AI SwingMax
Intellectia AI SwingMax

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Financial AI Agent
Financial AI Agent

LFWD News & Events

Events Timeline

(ET)
2025-12-03
08:20:00
Lifeward Receives Humana Medicare Approval for ReWalk 7
select
2025-11-17 (ET)
2025-11-17
08:09:10
Lifeward Secures Prior Authorization from UnitedHealthcare for ReWalk 7
select
2025-11-14 (ET)
2025-11-14
08:03:21
Lifeward projects FY25 revenue between $24 million and $26 million.
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.5
12-03Newsfilter
Lifeward Secures Humana Approval for ReWalk 7 Exoskeleton
  • Market Leadership: Lifeward's approval from Humana Medicare Advantage Plan enables nearly half of all Medicare Advantage enrollees to access the ReWalk 7 exoskeleton, further solidifying its leadership position in the medical technology sector.
  • Revenue Growth Potential: This approval is expected to enhance Lifeward's revenue and cash flow dynamics, thereby establishing a stronger foundation for sustainable growth in the U.S. market.
  • Promotion of Innovative Technology: Humana's endorsement reflects its commitment to supporting innovative medical technologies aimed at providing more reliable exoskeleton solutions for spinal cord injury patients, thereby improving their quality of life.
  • Accelerated Payer Adoption: As coverage for the ReWalk exoskeleton expands, Lifeward is experiencing a faster pace of prior authorization approvals, which not only increases reimbursement predictability but also creates favorable conditions for the company's future market expansion.
[object Object]
Preview
4.0
11-18Benzinga
HC Wainwright & Co. Reaffirms Buy Rating on Lifeward, Adjusts Price Target to $4.5

  • Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders, helping them stay informed and make timely decisions in the stock market.

  • Exclusive Content: The platform provides exclusive stories and insights generated by Benzinga reporters, enhancing the trading experience for its users.

  • Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, indicating a robust network for sharing market intelligence.

  • Market Success: Traders utilize Benzinga Pro's resources to gain a competitive edge and improve their chances of winning in the markets daily.

[object Object]
Preview
9.5
11-10Newsfilter
Lifeward Scheduled to Announce Third Quarter Financial Results on November 14, 2025

  • Financial Results Announcement: Lifeward Ltd. will release its third quarter 2025 financial results on November 14, 2025, before market opening, followed by a conference call at 8:30 a.m. EST.

  • Conference Call Access: Analysts and investors can join the conference call via toll-free numbers or through a live webcast available on Lifeward's website.

  • Company Overview: Lifeward specializes in innovative medical technology aimed at improving the lives of individuals with physical limitations, offering products like the ReWalk Exoskeleton and AlterG Anti-Gravity system.

  • Global Operations: Founded in 2001, Lifeward operates in the U.S., Israel, and Germany, focusing on delivering groundbreaking solutions for rehabilitation and recovery.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Lifeward Ltd (LFWD) stock price today?

The current price of LFWD is 0.7 USD — it has increased 1.45 % in the last trading day.

arrow icon

What is Lifeward Ltd (LFWD)'s business?

Lifeward Ltd, formerly known as ReWalk Robotics Ltd, is a medical device company. The Company is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The Company offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The Company offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.

arrow icon

What is the price predicton of LFWD Stock?

Wall Street analysts forecast LFWD stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LFWD is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Lifeward Ltd (LFWD)'s revenue for the last quarter?

Lifeward Ltd revenue for the last quarter amounts to 6.20M USD, increased 1.09 % YoY.

arrow icon

What is Lifeward Ltd (LFWD)'s earnings per share (EPS) for the last quarter?

Lifeward Ltd. EPS for the last quarter amounts to -0.20 USD, decreased -42.86 % YoY.

arrow icon

What changes have occurred in the market's expectations for Lifeward Ltd (LFWD)'s fundamentals?

The market is revising Upward the revenue expectations for Lifeward Ltd. (LFWD) for FY2025, with the revenue forecasts being adjusted by 0.64% over the past three months. During the same period, the stock price has changed by 32.08%.
arrow icon

How many employees does Lifeward Ltd (LFWD). have?

Lifeward Ltd (LFWD) has 80 emplpoyees as of December 05 2025.

arrow icon

What is Lifeward Ltd (LFWD) market cap?

Today LFWD has the market capitalization of 12.85M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free